Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

B-lymphoid or myeloid lineage identity of cell lines derived from chronic myeloid leukemia blast crisis.

Soh BN, Klein F, Feldhahn N, Müschen M.

Cancer Genet Cytogenet. 2005 Sep;161(2):187-8. No abstract available.

PMID:
16102593
2.

Mixed blast crisis of chronic myelogenous leukemia involving minimally differentiated myeloblast and megakaryoblast lineages.

Amemiya N, Yatomi Y, Yanagi M, Endo T, Ozaki Y.

Lab Hematol. 2004;10(4):254-5. No abstract available.

PMID:
15697094
3.

Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.

Oh SH, Park TS, Kim HR, Lee JY, Kim JH, Shin JH, Lee JN.

Leuk Res. 2009 Nov;33(11):e195-8. doi: 10.1016/j.leukres.2009.04.026. Epub 2009 May 17.

PMID:
19446879
4.

What can we learn from leukemia as for the process of lineage commitment in hematopoiesis?

Schmidt CA, Przybylski GK.

Int Rev Immunol. 2001 Feb;20(1):107-15. Review.

PMID:
11342300
5.

Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.

Padmanabhan V, Varma N, Dash S, Varma S.

Indian J Pathol Microbiol. 1996 Jan;39(1):13-7.

6.

'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features.

Cervantes F, Villamor N, Esteve J, Montoto S, Rives S, Rozman C, Montserrat E.

Br J Haematol. 1998 Jan;100(1):123-8.

PMID:
9450800
7.

Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.

Olsson-Strömberg U, Aleskog A, Björnberg A, Höglund M, Simonsson B, Bengtsson M, Barbany G, Larsson R, Lindhagen E.

Anticancer Drugs. 2006 Jul;17(6):631-9.

PMID:
16917208
8.

Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.

Miyazaki K, Yamasaki N, Oda H, Kuwata T, Kanno Y, Miyazaki M, Komeno Y, Kitaura J, Honda Z, Warming S, Jenkins NA, Copeland NG, Kitamura T, Nakamura T, Honda H.

Blood. 2009 May 7;113(19):4702-10. doi: 10.1182/blood-2007-05-088724. Epub 2009 Feb 20.

9.

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.

Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM, Melo JV.

Cancer Res. 2005 Oct 1;65(19):8912-9.

10.

[Heterogeneity of immunologic subtypes of blast crisis in chronic myeloid leukemia].

Frolov EA, Baryshnikov AIu, Moiseenkova IN, Tupitsyn NN, Turkina AG.

Gematol Transfuziol. 1992 May-Jun;37(5-6):6-10. Russian.

PMID:
1478435
11.

[Existence and significance of T-lymphoid crisis of chronic myeloid leukemia].

Kuriyama K.

Rinsho Ketsueki. 1990 May;31(5):625-32. Review. Japanese. No abstract available.

PMID:
2203919
12.

[Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].

Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.

Tsitologiia. 2007;49(10):889-900. Russian.

PMID:
18074781
13.

Megakaryoblastic lineage of peripheral blood blasts of CML blast crisis identified by budding dysplastic platelets.

Anand M, Kumar R, Singh S.

Am J Hematol. 2004 Apr;75(4):239-40. No abstract available.

14.

Extramedullary blast crisis in chronic myeloid leukemia--a case report.

Tondon R, Singh PA, Misra V, Singh M, Mohan S.

Indian J Pathol Microbiol. 2005 Apr;48(2):253-4.

PMID:
16758687
15.

Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.

Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.

Cancer Genet Cytogenet. 2008 Jan 1;180(1):60-4.

PMID:
18068536
16.

[Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease].

Filanovskaia LI, Togo AV, Shcherbakova EG, Blinov MN.

Vopr Med Khim. 1994 Jan-Feb;40(1):29-32. Russian.

PMID:
8122406
17.

Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia.

Otero L, Moellmann AC, Pombo-de-Oliveira MS, Ornellas MH, Pires V, Bouzas LF, Fernandez Tde S.

Eur J Haematol. 2007 Aug;79(2):179-81. Epub 2007 Jul 2. Review. No abstract available.

PMID:
17608714
18.

Chronic myeloid leukemia blast crisis arises from progenitors.

Michor F.

Stem Cells. 2007 May;25(5):1114-8. Epub 2007 Jan 11.

19.

A comment on Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.

Lazarevic VLj.

Leuk Res. 2010 Sep;34(9):1253. doi: 10.1016/j.leukres.2010.03.004. Epub 2010 Apr 7. No abstract available.

PMID:
20378169
20.

Blast crisis merely lymph nodal of chronic myeloid leukemia.

Piccinini L, Arigliano V, Artusi T.

Haematologica. 2002 Mar;87(3):EIM09. No abstract available.

PMID:
11869959

Supplemental Content

Support Center